IFNA1 and hepatitis B virus infection: A comprehensive understanding of these proteins can reveal critical mechanisms of host defense, potentially guiding the development of novel therapeutic strategies to enhance IFN efficacy, improve clinical cure rates in hepatitis B, and optimize patient outcomes (Table 1).